Anika Therapeutics (ANIK) Change in Intangibles (2025)
Anika Therapeutics' (ANIK) quarterly Change in Intangibles came in at $600000.0 in Q2 2025.
Anika Therapeutics (ANIK) Change in Intangibles (2025) Analysis & Trends
Anika Therapeutics (ANIK) has 1 years of Change in Intangibles data on file, last reported at $600000.0 in Q2 2025.
- On a quarterly basis, Change in Intangibles changed N/A year-over-year to $600000.0 in Q2 2025; TTM through Dec 2025 was $600000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $600000.0, changed N/A from the prior year.
- Change in Intangibles for Q2 2025 stood at $600000.0.
- Over the last five years, Change in Intangibles for ANIK reached as high as $600000.0 in Q2 2025 and fell as low as $600000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -107.94 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Anika Therapeutics | 203.64 Mn | 136.85 Mn | 19.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |